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Abstract Low density lipoproteins are highly sensitive to oxida- 
tion by copper salts, and such peroxidation is accompanied by 
macrophage scavenger eceptor recognition. This study shows 
that fresh human atherosclerotic material (aneurysms and endar- 
terectomies) can contain detectable amounts of redox active iron 
and copper that is chelatable from tissue homogenates. Such 
material is often prooxidant owards lipid peroxidation and deox- 
yribose degradation. Aneurysms and endarterectomies contain 
ferroxidase 1 activities, whereas only in aneurysms could caeru- 
loplasmin be immunologically detected. Ferroxidase 2 activity, 
characteristic of a copper-oxidised lipoprotein complex, could 
not, however, be detected in any of the atherosclerotic samples. 
A third ferroxidase activity, attributable to xanthine oxidase, was 
present in several aneurysms and endarterectomies. 
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1. Introduction 
Peroxidation of polyunsaturated fatty acids associated with 
low density lipoprotein (LDL) particles is thought o oCcur in 
the artery wall, and lead to the formation of a modified LDL 
recognised by the macrophage scavenger receptor [1,2]. Under 
such circumstances modified LDL uptake is not down-regu- 
lated and lipid-laden foam cells are often associated with ath- 
erosclerotic lesions [3]. The prooxidants that trigger lipid perox- 
idation of LDL in vivo are the subject of  considerable current 
interest. 
Copper salts have been shown to be remarkably effective at 
stimulating LDL  oxidation [4]. However, copper salts are 
tightly sequested in biological systems and are not normally 
available to catalyse lipid peroxidation. Recently, several inde- 
pendent lines of research suggest that prooxidant forms of 
copper may be present in the circulation and artery walls to 
stimulate lipid peroxidation [5,6]. Most, if not all of the copper 
present in human plasma is associated with the protein caeru- 
loplasmin, which has 6 tightly held copper atoms and a seventh 
that is easily dissociated (reviewed in [7]). This tightly held 
copper can be released in the presence of peroxynitrite [8] and 
structural modification of the protein changes its copper-de- 
pendent prooxidant/antioxidant ac ivity [6]. 
An important observation by Smith et al. [5] showed that 
chelatable forms of iron and copper are present in gruel sam- 
ples removed from atherosclerotic lesion at post-mortem. This 
together with the proposal that native caeruloplasmin s proox- 
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idant in the presence of copper salts [6], prompted the present 
study. 
2. Materials and methods 
2.1. Clinical material and preparation of samples 
Atheromatous material removed in the theatre was transported on 
ice to the laboratory, where the fresh material was immediately ana- 
lyzed for reactive metals Remaining aliquots were stored in liquid 
nitrogen. Contaminating blood was removed, and samples were washed 
in ice-cold 0.15 M NaC1. Lesions were incised with a scalpel and fatty 
semi-solid gruel removed and homogenised in 2 ml of ice-cold 0.15 M 
NaC1, prepared in metal ion-free distilled water. Aneurysms were ob- 
tained from abdominal aortic, carotid and femoral arteries, and endar- 
terectomies from coronary, carotid and femoral arteries. 
Approximately 10 mg samples of endarterectomies and 100 mg of 
aneurysms were present per ml of homogenate. The ratio of cholesterol- 
to-protein present in endarterectomies was 0.233 + 0.065 and that in 
aneurysms 0.027 _+ 0.010, confirming that endarterectomies had a 
greater proportion of cholesterol. 
2.2. Chelatable redox active copper 
Copper that can be chelated by 1,10-phenanthroline is complexed to 
DNA, and redox cycled with mercaptoethanol to release thiobarbituric 
acid (TBA)-reactive material from DNA [9]. TBA reactive material 
released isquantitatively related to copper content by the use of a pure 
standard of cupric chloride. 
2.3. Chelatable redox active iron 
Iron is chelated from biological material by bleomycin which binds 
to DNA. The Neomycin-iron complex is redox cycled with ascorbate 
to release TBA reactive material from DNA [10]. TBA reactive material 
released from DNA is quantitatively related to iron content by the use 
of ferric chloride standards. 
2.4. Caeruloplasmin assay 
Radial immunodiffusion plates (Behring-Hoechst, Hounslow, 
Middx.) for low concentrations of caeruloplasmin (LC-plates) were 
used as detailed by the manufacturers, with reference to pure standards 
of caeruloplasmin (Behring-Hoechst). 
2.5. Ferroxidase 1 activity 
Caeruloplasmin catalyses the oxidation of ferrous ions to the ferric 
state, at pH 6.5, which bind to apotransferrin toproduce a pink com- 
plex (A460nm). The kinetics of this reaction form an assay for ferrox- 
idase activity [11]. In our assay apo-ovotransferrin was substituted for 
apotransferrin. The specific contribution by caeruloplasmin (ferroxi- 
dase 1) was determined by inhibiting it in the presence of 1 mM azide. 
2.6. Ferroxidase 2 activity 
Total ferroxidase activity was measured as described above and re- 
peated in the presence of 1 mM azide. Ferroxidase 2 is an oxidised 
lipid--copper-protein complex which has enzyme-like activity which is 
not inhibited by azide. 
2.7. Ferroxidase 3 activity 
Xanthine oxidase has a ferroxidase activity [12] (ferroxidase 3) which 
can be inhibited by allopurinol. Assays were performed as described 
above. All ferroxidase activities were expressed as International Units. 
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One IU of ferroxidase transforms 1 pmol of ferrous ions to the ferric 
state under defined conditions. 
2.8. Xanthine oxidase 
Xanthine oxidase activity was determined at pH 7.4 by the formation 
of uric acid (A293m) from hypoxanthine. One unit of xanthine oxidase 
converts 1 ,umol of xanthine to uric acid per minute. 
2.9. Lipid peroxidation and deoxyribose degradation 
Linolenic acid miceUes [13], and deoxyribose [14] were used as sub- 
strates for organic and inorganic oxygen radical damage respectively. 
50/.tl of linolenic acid (10 mg/ml) was incubated in 10 mM sodium 
phosphate buffer, pH 7.4 (840/zl), with 100/tl ascorbic acid (1 mM). 
10 ~tl of homogenate was added to assess stimulation, or inhibition, of 
the reaction. The mixture was incubated at 37°C for 20 rain and the 
amount of TBA-reactive material released from linolenic acid measured 
as fluorescence at 532 nm. A similar procedure wasadopted for deox- 
yribose, where 10mM deoxyribose was used instead of linolenic acid. 
2.10. Other techniques 
Thiobarbituric acid-reactive substances in atherosclerotic material 
were determined by heating homogenised samples with 28% (w/v) 
trichloroacetic acid and 1% (w/v) thiobarbituric a id for 15 min at 
100°C. The resulting chromogen was extracted into butan-l-ol and its 
fluorescence measured at 532 rim. Total proteins were determined by 
the Lowry method. 
3. Results 
Freshly taken human atherosclerotic material removed at 
surgery and analysed in the intensive care laboratory within the 
shortest possible time often showed the presence of pro-oxidant 
forms of iron and copper that could be chelated from solution. 
Bleomycin-chelatable iron was detected in 7 of 13 endarterecto- 
mies (ETMS) and in 5 of 10 aneurysms (ARMS) whereas 
phenanthroline-chelatable copper was present in 12 ETMS and 
6 ARMS (Table 1). Homogenates of di ferent atherosclerotic 
material could both stimulate and inhibit model systems gener- 
ating peroxyl radicals (linolenic acid micelles), and hydroxyl 
radicals (deoxyribose degradation). ETMS stimulated lipid per- 
oxidation by 7% whereas ARMS stimulated by 4%. Mean val- 
ues in the deoxyribose assay were 41% inhibition for ETMS and 
1% stimulation for ARMS. Appropriate controls for en- 
dogenous TBA-reactive material were included. 
Ferroxidase activity inhibitable by azide, and therefore at- 
tributable to caeruloplasmin, was present in both ETMS and 
ARMS, however, only in ARMS could the protein be recogni- 
sed by an antibody assay (Table 2). Although TBA-reactive 
material was detectable in both ETMS and ARMS, we found 
no evidence for oxidised lipid~zopper-protein complexes char- 
Table 1 
Chelatable iron and copper, and prooxidant/antioxidant activities of 
atherosclerotic material 
Endarterectomies Aneurysms 
(n = 13) ± S.E.M. (n = 10) ± S.E.M. 
Phenanthroline-chelatable 
copper (nmol/mg protein) 0.3 + 0.1 0.3 ± 0.2 
Bleomycin-chelatable iron
(nmol/mg protein) 0.7 + 0.3 0.4 + 0.2 
Effect on linolenic acid 
micelles (% stimulation 
[S] or inhibition [I]) 42% 1-109% S 34% 1-113% S 
Effect on deoxyribose 
degradation (I orS) 89% I~J,0% S 95% 1-181% S 
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Table 2 
Ferroxidase activities of atherosclerotic material 
Endarterectomies Aneurysms 
(n = 13) + S.E.M. (n = 10) + S.E.M. 
Ferroxidase 1 (caeruloplas- 
min, azide inhibitable) 
(IU/mg protein) 7.0 ___ 2.8 
Caeruloplasmin 
(¢tmol/mg protein) 0 
Ferroxidase 2 (oxidised 
lipid/copper complex 
not inhibited by azide) 
(IU/mg protein) 0 
TBA-reactivity (nmol 
MDA/mg protein) 0.4 i 0.2 
Ferroxidase 3 
(xanthine oxidase in- 
hibited by allopurinol) 
(IU/mg protein) 
Xanthinc oxidase activity 
(U/rag protein) 
6.3 + 1.4 
14.3 + 3.4 
0 
0.2 ± 0.1 
2.4 + 1.7 (n : 8) 0.5 + 0.2 (n : 8) 
0.6 ± 0.5 (n = 8) 0.3 + 0.1 (n = 8) 
acteristic of material with ferroxidase 2 activity. Since most 
atherosclerotic samples had a higher total ferroxidase activity 
than could be accounted for by ferroxidase 1,plus 2, we assayed 
samples for ferroxidase activity dependent upon xanthine oxi- 
dase; here referred to as ferroxidase 3.Both ETMS and ARMS 
samples howed the presence of low and variable ferroxidase 
3 activities inhibitable by allopurinol. The presence of xanthine 
oxidase activity was confirmed by measuring uric acid forma- 
tion in the presence of hypoxanthine (Table 2). Four ETMS 
samples out of 8 showed ferroxidase 3 activity whereas 6 out 
of 8 ARMS samples howed the same activity (Table 2). 
4. Discussion 
The current hypothesis that lipid peroxidation is a key event 
in the development of atherosclerosis [15] requires that proox- 
idant factors exceed ant±oxidant defenses in order to promote 
molecular damage. Studies with isolated LDL preparations 
have uniformly shown that copper salts are devastatingly effec- 
tive at promoting LDL modification for recognition by the 
scavenger receptor of macrophages. However, simple copper 
salts do not exist in vivo because the metal is readily ligated to 
ubiquitous amino residues, and chelatable copper only appears 
in separated human plasma when it is stored or mishandled 
[16], due to proteolytic damage to caeruloplasmin. Caeruloplas- 
min is regarded as an important plasma ant±oxidant towards 
iron-driven free radical reactions [17,18] since it has a ferroxi- 
dase activity [19]. This activity can be inhibited by azide. 
Copper fragments released from degraded caeruloplasmin 
are known to cause peroxidation oflipoproteins, and the result- 
ing oxidised lipid-copper-protein complex has a ferroxidase- 
like activity similar to that of caeruloplasmin [20], but which is 
not inhibited by azide. Intact native caeruloplasmin has re- 
cently been ascribed a prooxidant property towards copper- 
stimulated LDL oxidation [6], which changes to an ant±oxidant 
activity when the protein is partly degraded [6]. The reported 
presence of chelatable redox active copper in gruel samples 
taken at post mortem [5] and its possible synergism with native 
caeruloplasmin in promoting LDL oxidation prompted us to 
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look for both components in flesh human atherosclerotic sam- 
ples removed at surgery. 
Endarterectomies and aneurysms contained similar amounts 
of chelatable copper and ferroxidase 1activity. However, caer- 
uloplasmin could only be detected by radial immunodiffusion 
in aneurysms. This in part may reflect the poor sensitivity of 
an assay system developed for use with plasma, as well as the 
difference in origin and structure of endarterectomies and an- 
eurysms. Aneurysms will contain substantial mounts of artery 
wall structure, whereas endarterectomies are more comparable 
to the post-mortem samples of gruel previously reported [5]. 
Surprisingly, no ferroxidase 2 activity characteristic of copper- 
oxidised lipoproteins was detectable by our assay technique in 
either materials. Since the total ferroxidase activity often ex- 
ceeded that which could be accounted for by ferroxidase 1 and 
2 activities, we assumed other molecules were contributing fer- 
roxidase activities. Xanthine oxidase has been reported to have 
a significant ferroxidase activity [12] and both ferroxidase and 
xanthine oxidase activities inhibitable by allopurinol were pres- 
ent in several atherosclerotic samples. 
We conclude that chelatable forms of copper and iron are 
present in freshly taken atherosclerotic material, and that other 
pro-oxidants uch as xanthine oxidase and possibly caeru- 
loplasmin (when reactive copper is present) may also contribute 
to the development and amplification of oxidative processes in 
atherosclerotic lesions. There were, however, no statistically 
significant correlations between chelatable metals nd the stim- 
ulation of lipid peroxidation, suggesting that other pro-oxi- 
dants are also involved. 
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